290 related articles for article (PubMed ID: 17204409)
1. Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.
Flaten GE; Skar M; Luthman K; Brandl M
Eur J Pharm Sci; 2007 Mar; 30(3-4):324-32. PubMed ID: 17204409
[TBL] [Abstract][Full Text] [Related]
2. Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes.
Flaten GE; Bunjes H; Luthman K; Brandl M
Eur J Pharm Sci; 2006 Jul; 28(4):336-43. PubMed ID: 16697561
[TBL] [Abstract][Full Text] [Related]
3. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.
Flaten GE; Dhanikula AB; Luthman K; Brandl M
Eur J Pharm Sci; 2006 Jan; 27(1):80-90. PubMed ID: 16246536
[TBL] [Abstract][Full Text] [Related]
4. In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier.
Kanzer J; Tho I; Flaten GE; Mägerlein M; Hölig P; Fricker G; Brandl M
J Pharm Pharmacol; 2010 Nov; 62(11):1591-8. PubMed ID: 21039543
[TBL] [Abstract][Full Text] [Related]
5. Drug permeability across a phospholipid vesicle-based barrier 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability.
Flaten GE; Luthman K; Vasskog T; Brandl M
Eur J Pharm Sci; 2008 Jul; 34(2-3):173-80. PubMed ID: 18499410
[TBL] [Abstract][Full Text] [Related]
6. Application of simulated intestinal fluid on the phospholipid vesicle-based drug permeation assay.
Fischer SM; Buckley ST; Kirchmeyer W; Fricker G; Brandl M
Int J Pharm; 2012 Jan; 422(1-2):52-8. PubMed ID: 22027395
[TBL] [Abstract][Full Text] [Related]
7. In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants.
Fischer SM; Flaten GE; Hagesæther E; Fricker G; Brandl M
J Pharm Pharmacol; 2011 Aug; 63(8):1022-30. PubMed ID: 21718285
[TBL] [Abstract][Full Text] [Related]
8. Surface-dependent transitions during self-assembly of phospholipid membranes on mica, silica, and glass.
Benes M; Billy D; Benda A; Speijer H; Hof M; Hermens WT
Langmuir; 2004 Nov; 20(23):10129-37. PubMed ID: 15518504
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid subclass specific alterations in the passive ion permeability of membrane bilayers: separation of enthalpic and entropic contributions to transbilayer ion flux.
Zeng Y; Han X; Gross RW
Biochemistry; 1998 Feb; 37(8):2346-55. PubMed ID: 9485381
[TBL] [Abstract][Full Text] [Related]
10. Nimesulide interaction with membrane model systems: are membrane physical effects involved in nimesulide mitochondrial toxicity?
Monteiro JP; Martins AF; Lúcio M; Reis S; Pinheiro TJ; Geraldes CF; Oliveira PJ; Jurado AS
Toxicol In Vitro; 2011 Sep; 25(6):1215-23. PubMed ID: 21645611
[TBL] [Abstract][Full Text] [Related]
11. Screening for the drug-phospholipid interaction: correlation to phospholipidosis.
Alakoskela JM; Vitovic P; Kinnunen PK
ChemMedChem; 2009 Aug; 4(8):1224-51. PubMed ID: 19551800
[TBL] [Abstract][Full Text] [Related]
12. Calcein permeation across phosphatidylcholine bilayer membrane: effects of membrane fluidity, liposome size, and immobilization.
Shimanouchi T; Ishii H; Yoshimoto N; Umakoshi H; Kuboi R
Colloids Surf B Biointerfaces; 2009 Oct; 73(1):156-60. PubMed ID: 19560324
[TBL] [Abstract][Full Text] [Related]
13. Bilayer phase transitions of N-methylated dioleoylphosphatidylethanolamines under high pressure.
Kusube M; Goto M; Tamai N; Matsuki H; Kaneshina S
Chem Phys Lipids; 2006 Jul; 142(1-2):94-102. PubMed ID: 16620796
[TBL] [Abstract][Full Text] [Related]
14. Photosensitizing effect of some nonsteroidal antiinflammatory drugs on natural and artificial membranes: dependence on phospholipid composition.
De Guidi G; Ragusa S; Cambria MT; Belvedere A; Catalfo A; Cambria A
Chem Res Toxicol; 2005 Feb; 18(2):204-12. PubMed ID: 15720124
[TBL] [Abstract][Full Text] [Related]
15. Interaction of phloretin and 6-ketocholestanol with DPPC-liposomes as phospholipid model membranes.
Auner BG; O'Neill MA; Valenta C; Hadgraft J
Int J Pharm; 2005 Apr; 294(1-2):149-55. PubMed ID: 15814239
[TBL] [Abstract][Full Text] [Related]
16. Configuration of polyisoprenoids affects the permeability and thermotropic properties of phospholipid/polyisoprenoid model membranes.
Ciepichal E; Jemiola-Rzeminska M; Hertel J; Swiezewska E; Strzalka K
Chem Phys Lipids; 2011 May; 164(4):300-6. PubMed ID: 21440533
[TBL] [Abstract][Full Text] [Related]
17. Effects of proteins on thermotropic phase transitions of phospholipid membranes.
Papahadjopoulos D; Moscarello M; Eylar EH; Isac T
Biochim Biophys Acta; 1975 Sep; 401(3):317-35. PubMed ID: 52374
[TBL] [Abstract][Full Text] [Related]
18. Investigation of vesicle electrokinetic chromatography as an in vitro assay for the estimation of intestinal permeability of pharmaceutical drug candidates.
Pascoe RJ; Masucci JA; Foley JP
Electrophoresis; 2006 Feb; 27(4):793-804. PubMed ID: 16411277
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting leakage of trapped solutes from phospholipid vesicles during thermotropic phase transitions.
Hays LM; Crowe JH; Wolkers W; Rudenko S
Cryobiology; 2001 Mar; 42(2):88-102. PubMed ID: 11448111
[TBL] [Abstract][Full Text] [Related]
20. Role of hydrophobic interactions in the adsorption of poly(ethylene glycol) chains on phospholipid membranes investigated with a quartz crystal microbalance.
Liu G; Fu L; Zhang G
J Phys Chem B; 2009 Mar; 113(11):3365-9. PubMed ID: 19227992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
